KYMERA THERAPEUTICS INC (KYMR)
US5015751044 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to KYMR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 52.26. This target is 56.69% above the current price.
KYMR was analyzed by 22 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about KYMR.
In the previous month the buy percentage consensus was at a similar level.
KYMR was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-22 | Oppenheimer | Initiate | Outperform |
| 2024-03-01 | Truist Securities | Maintains | Buy -> Buy |
| 2024-02-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-23 | Stifel | Maintains | Buy -> Buy |
| 2024-02-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-15 | Wolfe Research | Initiate | Peer Perform |
| 2024-01-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-12-19 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-11-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-11-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-07 | Stifel | Maintains | Buy -> Buy |
| 2023-08-04 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-30 | Truist Securities | Initiate | Buy |
| 2023-06-15 | Stifel | Reiterate | Buy -> Buy |
| 2023-06-05 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-05-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-05-05 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2023-05-05 | Credit Suisse | Maintains | Neutral |
| 2023-02-24 | Credit Suisse | Maintains | Neutral |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-03 | Wells Fargo | Maintains | Overweight |
| 2022-12-19 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-16 | Goldman Sachs | Maintains | Buy |
| 2022-12-15 | SVB Leerink | Maintains | Market Perform |
| 2022-12-06 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2022-11-08 | Wells Fargo | Maintains | Overweight |
| 2022-11-08 | Raymond James | Initiate | Market Perform |